HCW Biologics (HCWB) Times Interest Earned (2020 - 2025)
HCW Biologics' (HCWB) quarterly Times Interest Earned came in at -$21.03 in Q4 2025, down 17.52% YoY from -$25.5 in Q4 2024, and up 18.81% on a QoQ basis from -$25.91 in Q3 2025.
HCW Biologics (HCWB) Times Interest Earned (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Times Interest Earned data on file, last reported at -$21.03 in Q4 2025.
- Quarterly Times Interest Earned fell 17.52% year-over-year to -$21.03 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$16.0 (up 69.33% YoY) and the FY2025 annual result came in at -$0.48, up 57.27% from the prior year.
- Times Interest Earned advanced to -$21.03 in Q4 2025, from -$25.91 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $7567.2 in Q4 2023 to a low of -$135.03 in Q1 2022.
- A 5-year average of $381.9 and a median of -$20.76 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned jumped 12715.02% — and 2024, when it sank 3683.07%.
- Tracing HCWB's Times Interest Earned over 5 years: stood at -$2.77 in 2021, then slumped by 2066.65% to -$59.99 in 2022, then surged by 12715.02% to $7567.2 in 2023, then plunged by 100.24% to -$17.9 in 2024, then dropped by 17.52% to -$21.03 in 2025.
- The last three Times Interest Earned figures came in at -$21.03 (Q4 2025), -$25.91 (Q3 2025), and -$15.15 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | -31.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.03 |
| Sep 30, 2025 | -25.91 |
| Jun 30, 2025 | -15.15 |
| Mar 31, 2025 | -7.68 |
| Dec 31, 2024 | -17.90 |
| Sep 30, 2024 | -16.09 |
| Jun 30, 2024 | -94.80 |
| Dec 31, 2023 | 7,567.25 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -2.51 |
| Mar 31, 2023 | -57.37 |
| Dec 31, 2022 | -59.99 |
| Sep 30, 2022 | -23.46 |
| Jun 30, 2022 | -20.49 |
| Mar 31, 2022 | -135.03 |
| Dec 31, 2021 | -2.77 |
| Sep 30, 2021 | -113.67 |
| Jun 30, 2021 | -76.42 |
| Dec 31, 2020 | 52.74 |